Home › NCT06802133
Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)
RecruitingObservational study
Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * The general population will be included in the study where a dura substitute is required for the repair of dura mater. Exclusion Criteria: * Patients that have conditions which are contraindicated per the instructions for use (IFU) would be excluded.
About the study
Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.
What is being tested
- Post Market Study (other)
Sponsor: Collagen Matrix · Participants: 118 · Started: Jan 13, 2025
Contact the study team
- Meenakshi Paliwal · Phone: 2014051477
- Peggy Hansen · Phone: 201-405-1477
Official record on ClinicalTrials.gov — NCT06802133
Locations in the U.S.
| Georgia | Augusta University, Augusta |
| Massachusetts | Massachusetts General Hospital, Boston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.